Guided by insights into how mice recover after H1N1 flu, researchers at Harvard Medical School and Brigham and Women's Hospital, together with researchers at A*STAR of Singapore, have cloned three distinct stem cells from ...
Oct 27, 2011
0
1
Pulmonary diseases are a leading cause of morbidity and mortality worldwide. For many progressive lung diseases like idiopathic pulmonary fibrosis (IPF), a key issue is a low supply of new stem cells to repair and reverse ...
Apr 10, 2024
0
136
Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal disease characterized by lung fibrosis and declining lung function. There are currently few effective treatments for IPF, and the median survival following diagnosis ...
Apr 7, 2016
0
6
(Medical Xpress) -- In an age where personalized medicine is within reach, a one-size-fits-all approach just won’t cut it. A group of North American researchers have identified two “modifier” genes in the genomes ...
May 25, 2011
0
0
Researchers find key molecule that could lead to new therapies for anemia and other iron disorders
May 11, 2017
0
104
Using the latest technologies—including both single-nuclear sequencing of mice and human liver tissue and advanced 3D glass imaging of mice to characterize key scar-producing liver cells—researchers have uncovered novel ...
Jan 4, 2023
0
58
Researchers at the University of Montreal and its affiliated CHU Sainte-Justine children's hospital are warning parents that difficult eaters could have underlying psychological issues, as they have found that restrictive ...
Oct 8, 2014
0
0
UC San Francisco researchers have discovered a new biological pathway in fat cells that could explain why some people with obesity are at high risk for metabolic diseases such as type 2 diabetes. The new findings—demonstrated ...
Jan 15, 2018
0
315
A new University of Iowa study suggests there are two root causes of a type of diabetes associated with cystic fibrosis (CF). The findings, which already have sparked a clinical trial, may guide development of new treatments ...
Sep 17, 2012
0
0
Researchers at Helmholtz Zentrum München, in collaboration with an international team, have identified a potential novel drug target for idiopathic pulmonary fibrosis, a dangerous chronic lung disease. They elucidated a ...
Jun 8, 2015
0
164
